Breast gene link to lung cancer death

A gene that increases susceptibility to breast cancer may also predict worse outcomes in lung cancer patients, a European study has shown.

High levels of the BRCA1 breast cancer gene have been shown to double the risk of mortality over three years following surgery for non-small cell lung cancer (NSCLC).

Outcomes in NSCLC patients could be improved by offering adjuvant chemotherapy to those with high levels of the gene, the researchers suggested.

They analysed tumour samples taken from 126 Polish patients during surgery for NSCLC. They then measured levels of five genes believed to play a role in progression of NSCLC, including BRCA1.

Of the five genes, only BRCA1 was found to be predictive of survival. Patients with high levels of BRCA1 expression had a 98 per cent increased risk of dying within three years of surgery, compared with patients with low levels of BRCA1.

In the 36 patients whose tumours had high levels of BRCA1, event-free survival was 22 months on average.

Examination of NSCLC tumour samples from a separate group of 58 patients confirmed high BRCA1 expression more than doubled the risk of death.

Speaking at the European Cancer Conference in Barcelona last week, lead researcher Dr Rafael Rosell, from the Catalan Institute of Oncology in Barcelona, said: 'Our research shows that patients whose tumours had high BRCA1 expression had worse survival and should be candidates for adjuvant chemotherapy.'

He added that earlier studies had shown that different levels of BRCA1 expression affect response to different types of chemotherapy.

'BRCA1 could be a landmark predictor of chemosensitivity in NSCLC. We believe patients with the highest expression levels should receive antimicrotubule, non-platinum-based chemotherapy,' he said.

Comment below and tell us what you think

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:


Just published

NHS prescription and packet of pills

GPs can now prescribe flu antivirals on the NHS

GPs and other prescribers are now able to issue NHS prescriptions for antivirals...

GP sign

Prevention set to be key battleground for 2024 GP contract

Negotiations on a new GP contract from 2024/25 will need to 'align closely' with...

Talking General Practice logo

Podcast: What makes a strong PCN and how will integrated care systems affect networks?

Talking General Practice speaks to GP and PCN clinical director Professor Aruna Garcea,...

Money

GP core funding rise outstripped by staff pay awards under five-year contract

Staff pay awards have outstripped increases in core GP practice funding between 2019/20...

BMA sign

Fifth of GP time spent on non-medical work as NHS absorbs cost of 'government failure'

Doctors are 'picking up the pieces of government failures' as the cost-of-living...

COPD

How the five fundamentals of COPD care can help GPs support patients

GP Dr Andrew Whittamore, clinical lead at Asthma + Lung UK, explains NICE’s five...